当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析

华海药业

(600521)

  

流通市值:254.83亿  总市值:254.83亿
流通股本:14.97亿   总股本:14.97亿

华海药业(600521)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.74亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益959958.50万元,未分配利润556318.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2115269.16万元,负债1155310.66万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入6,408,881,906.054,516,353,788.972,368,563,881.429,547,425,412.4
营业总成本5,972,319,712.384,001,688,219.952,002,446,656.27,978,739,192.17
其他经营收益
营业利润555,157,968.34541,255,245.22376,768,523.141,470,788,599.09
利润总额549,156,742.39542,860,973.47375,012,300.241,463,608,474.95
净利润373,930,103.93405,158,861.54296,039,678.321,107,463,116.83
每股收益
其他综合收益-343,912.192,468,726.33739,654.29-110,875.97
综合收益总额373,586,191.74407,627,587.87296,779,332.611,107,352,240.86
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计8,647,950,847.318,899,110,228.739,462,382,014.628,483,148,001.25
非流动资产:
非流动资产合计12,504,740,748.0912,366,788,240.7512,035,007,077.1711,778,206,968.67
资产总计21,152,691,595.421,265,898,469.4821,497,389,091.7920,261,354,969.92
流动负债:
流动负债合计6,534,113,590.565,699,401,455.325,845,558,391.655,975,663,102.39
非流动负债:
非流动负债合计5,018,993,002.435,561,365,499.735,749,196,460.155,265,657,716.62
负债合计11,553,106,592.9911,260,766,955.0511,594,754,851.811,241,320,819.01
所有者权益(或股东权益):
归属于母公司股东权益合计9,509,925,669.119,910,300,224.439,779,249,594.438,897,779,286.94
股东权益合计9,599,585,002.4110,005,131,514.439,902,634,239.999,020,034,150.91
负债和股东权益合计21,152,691,595.421,265,898,469.4821,497,389,091.7920,261,354,969.92
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计6,901,295,948.684,598,112,323.592,339,998,592.029,567,245,725.87
经营活动现金流出小计6,248,909,276.544,228,474,611.062,144,890,933.167,394,581,802.06
经营活动产生的现金流量净额652,386,672.14369,637,712.53195,107,658.862,172,663,923.81
投资活动产生的现金流量:
投资活动现金流入小计194,618,841.5876,504,440.7820,067,013.731,710,230.09
投资活动现金流出小计1,303,981,134.49875,424,761.71452,226,040.731,951,986,252.3
投资活动产生的现金流量净额-1,109,362,292.91-798,920,320.93-432,159,027.03-1,920,276,022.21
筹资活动产生的现金流量:
筹资活动现金流入小计4,245,589,245.882,144,748,145.881,737,502,068.976,201,877,610
筹资活动现金流出小计3,888,396,173.241,615,705,090.56781,873,469.886,334,789,676.27
筹资活动产生的现金流量净额357,193,072.64529,043,055.32955,628,599.09-132,912,066.27
汇率变动对现金及现金等价物的影响-10,772,784.367,777,954.175,149,356.7451,158,021.95
现金及现金等价物净增加额-110,555,332.49107,538,401.09723,726,587.66170,633,857.28
期末现金及现金等价物余额1,367,044,887.521,585,138,621.12,201,326,807.671,477,600,220.01
补充资料:
现金及现金等价物的净增加额-107,538,401.09-170,633,857.28
最新报告期:2025-11-09
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,王宏雨0.250.450.542025-11-09
TOP↑